Soy isoflavone supplementation in healthy men prevents NF-kappaB activation by TNF-alpha in blood lymphocytes.

Author: Davis JN et al.
Publication: Free Radic Biol Med 2001;30:1293-1302.

The purpose of this study is to investigate the association between intake of soy and a decreased cancer risk. It is believed that soy isoflavones are the anti-cancer compounds but it's not exact mechanism is not yet known.

The soy isoflavones, genistein and daidzein, have antioxidant properties and it's believed that the anti-cancer effect is linked to this antioxidant effect. Previous in-vitro studies have shown demonstrated that the soy isoflavone genistein, but not daidzein inhibits the activation of the redox-sensitive transcription factor, NF-kappaB, in prostate cancer cells. In-vivo test also showed that 50 mg isoflavones mixture, consumed twice daily for 3 weeks have effect on the NF-kappaB activation in the blood lymphocytes. Isoflavones supplemention also resulted in a reduction of 5-hydroxymethyl-2'-deoxyuridine, a marker for oxidative DNA damage.

This preliminary study demonstrates that soy isoflavone may protect cells from oxidative stress and decreasing DNA adduct levels.

If you like this page, please click on the +1 button at the top right. Thanks a lot!